Key Insights
The European diabetic care devices market, valued at €8.03 billion in 2025, is projected to experience robust growth, driven by rising prevalence of diabetes, an aging population, and increasing awareness about effective diabetes management. A Compound Annual Growth Rate (CAGR) of 6.18% from 2025 to 2033 signifies substantial market expansion. Key growth drivers include technological advancements in continuous glucose monitoring (CGM) systems, the increasing adoption of insulin pumps and pen injectors offering improved convenience and accuracy, and the expanding availability of integrated diabetes management solutions. The market is segmented into monitoring devices (self-monitoring blood glucose (SMBG) devices and CGMs), and management devices (insulin pumps, infusion sets, insulin syringes, cartridges in reusable pens, insulin disposable pens, and jet injectors). While the SMBG segment currently holds a significant market share, the CGM segment is witnessing exponential growth due to its real-time data capabilities and improved patient outcomes. However, high costs associated with advanced devices like CGMs and insulin pumps, along with variations in healthcare reimbursement policies across European countries, pose challenges to market penetration. Germany, France, the United Kingdom, and Italy represent the largest national markets within Europe, reflecting higher diabetes prevalence and better healthcare infrastructure in these regions. The competitive landscape is characterized by major players such as Roche Diabetes Care, Abbott Diabetes Care, Medtronic, and Dexcom, along with several smaller companies focusing on niche technologies or specific device types. Future growth will depend on further technological innovation, improved affordability, and supportive healthcare policies focused on proactive diabetes management and prevention.
The market's growth trajectory is expected to be influenced by several factors. The development of more accurate, user-friendly, and minimally invasive devices will continue to fuel market expansion. Growing telehealth adoption, offering remote monitoring and support for patients, is likely to increase the usage of connected devices. Furthermore, the increasing focus on personalized diabetes management, integrating data from various sources to tailor treatment plans, will likely drive demand for sophisticated integrated solutions. Regulatory approvals for innovative devices and the expansion of insurance coverage for advanced technologies will also significantly impact market growth. However, concerns regarding device accuracy, potential side effects, and data security related to connected devices need to be addressed to maintain consumer trust and ensure the sustained growth of the European diabetic care devices market.
Europe Diabetic Care Devices Market: A Comprehensive Report (2019-2033)
This in-depth report provides a comprehensive analysis of the Europe Diabetic Care Devices Market, offering invaluable insights for industry professionals, investors, and strategic decision-makers. Covering the period from 2019 to 2033, with a base year of 2025 and a forecast period of 2025-2033, this report dissects market dynamics, competitive landscapes, and future growth opportunities. The report leverages extensive data analysis and expert insights to provide actionable intelligence on this rapidly evolving market. Key players like Rossmax, Agamatrix Inc, Roche Diabetes Care, Bionime Corporation, Sanofi, Eli Lilly, Novo Nordisk A/S, Abbott Diabetes Care, LifeScan, Medtronic, Dexcom Inc, Ascensia Diabetes Care, and Insulet Corporation are profiled, offering a detailed understanding of their market share and strategies.
Europe Diabetic Care Devices Market Market Structure & Innovation Trends
This section analyzes the market's structure, highlighting concentration levels, innovation drivers, and regulatory influences. We explore the impact of product substitutes, end-user demographics, and mergers & acquisitions (M&A) activities on market dynamics. The report estimates the market share of major players, providing a detailed overview of the competitive landscape. While precise M&A deal values for the specific period are not publicly available in a consolidated manner, we analyze the frequency and impact of such activities on market consolidation and innovation. The regulatory framework, including approvals and certifications across different European countries, significantly impacts the market, specifically the introduction of new devices and technologies.
- Market Concentration: High (xx%), driven by the dominance of a few major players.
- Innovation Drivers: Technological advancements in CGM, improved insulin delivery systems, and personalized diabetes management.
- Regulatory Landscape: Stringent regulations influence product approval timelines and market entry.
- Product Substitutes: Limited substitutes, although advancements in lifestyle management and alternative therapies pose indirect competition.
- End-User Demographics: A growing elderly population and increasing prevalence of type 2 diabetes drive market demand.
- M&A Activity: Moderate level of M&A activity observed in the historical period (2019-2024), leading to market consolidation and potential value creation.
Europe Diabetic Care Devices Market Market Dynamics & Trends
This section examines the driving forces behind market growth, including technological advancements, evolving consumer preferences, and competitive dynamics. We project a Compound Annual Growth Rate (CAGR) of xx% for the forecast period (2025-2033), driven by factors such as increased diabetes prevalence, rising healthcare expenditure, and technological innovations such as continuous glucose monitoring (CGM) systems and advanced insulin delivery devices. Market penetration of CGM devices is expected to increase to xx% by 2033, showcasing the significant growth in this sector. Technological disruptions, such as the development of artificial pancreas systems and improved data analytics capabilities, further propel market expansion.
Dominant Regions & Segments in Europe Diabetic Care Devices Market
This section identifies leading regions, countries, and segments within the European Diabetic Care Devices market. We provide a detailed analysis of market dominance, identifying key factors such as healthcare infrastructure, economic policies, and prevalence rates in each region. The analysis across various segments – Self-monitoring Blood Glucose Devices (SMBG), Continuous Glucose Monitoring (CGM) Devices, Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, and Jet Injectors— pinpoints growth drivers for each segment.
- Leading Region: Western Europe (Germany, UK, France) due to high diabetes prevalence, advanced healthcare infrastructure, and strong regulatory support.
- Key Segment Drivers:
- SMBG Devices: High adoption rates due to affordability and ease of use.
- CGM Devices: Rapid growth due to improved accuracy, convenience, and better diabetes management capabilities.
- Insulin Delivery Systems: Consistent demand driven by rising number of insulin-dependent patients.
- Country-Specific Analysis: Germany demonstrates high market penetration due to its advanced healthcare system and high diabetes prevalence, followed by the UK and France. Specific economic policies and healthcare reforms in each country impact market growth.
Europe Diabetic Care Devices Market Product Innovations
Recent years have witnessed significant product innovations in the European diabetic care devices market. This section highlights key advancements, including the launch of more user-friendly CGM systems and improved insulin delivery methods. The focus is on technological enhancements that offer enhanced accuracy, convenience, and improved patient outcomes. The market sees growing demand for integrated devices and remote monitoring capabilities, enabling better data-driven diabetes management. For example, Dexcom's launch of the Dexcom ONE+ in February 2024 significantly impacted the CGM market segment, offering a customizable real-time solution.
Report Scope & Segmentation Analysis
This report segments the European Diabetic Care Devices Market based on device type (Monitoring Devices, Management Devices), specific device categories (SMBG Devices, Lancets, CGM Devices, Insulin Pumps, Infusion Sets, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors), and geography. Each segment's growth projections, market size, and competitive dynamics are analyzed. For example, the CGM segment is projected to witness the highest growth rate due to technological advancements and increased patient adoption.
- Monitoring Devices: SMBG and CGM devices constitute the majority of the market share.
- Management Devices: Insulin pumps and pen-based delivery systems make up this significant segment.
Key Drivers of Europe Diabetic Care Devices Market Growth
Several factors fuel the growth of the European Diabetic Care Devices Market. Increased prevalence of diabetes across various age groups, coupled with rising healthcare expenditure, is a major driver. Technological advancements leading to improved device accuracy, convenience, and features that aid in better self-management are also significant growth stimulants. Government initiatives aimed at enhancing diabetes management and public awareness campaigns further boost market expansion.
Challenges in the Europe Diabetic Care Devices Market Sector
Despite strong growth prospects, the European Diabetic Care Devices Market faces challenges. Stringent regulatory approvals and reimbursement policies for new devices can cause market entry barriers. Supply chain disruptions and fluctuations in raw material prices can affect production and pricing. Intense competition among established players and emerging market entrants is another key hurdle. High device costs pose a significant barrier to affordability for many patients.
Emerging Opportunities in Europe Diabetic Care Devices Market
The market presents several lucrative opportunities. The increasing adoption of digital health technologies presents prospects for connected devices and remote patient monitoring. Expansion into underserved markets within Europe, and the development of innovative devices catering to specific patient needs, create additional avenues for growth. Artificial intelligence (AI)-driven solutions for personalized diabetes management offer considerable potential.
Leading Players in the Europe Diabetic Care Devices Market Market
- Rossmax
- Agamatrix Inc
- Roche Diabetes Care
- Bionime Corporation
- Sanofi
- Eli Lilly
- Novo Nordisk A/S
- Abbott Diabetes Care
- LifeScan
- Medtronic
- Dexcom Inc
- Ascensia Diabetes Care
- Insulet Corporation
Key Developments in Europe Diabetic Care Devices Market Industry
- February 2024: Dexcom launched the Dexcom ONE+, a customizable real-time CGM solution, enhancing market competitiveness in the CGM segment.
- June 2022: Cequr introduced the Insulin Pen 2.0TM, a wearable insulin delivery device with an integrated blood glucose meter, demonstrating innovative technology improving patient convenience.
Future Outlook for Europe Diabetic Care Devices Market Market
The European Diabetic Care Devices Market is poised for robust growth driven by several factors. The rising prevalence of diabetes, coupled with continuous technological advancements, points toward significant market expansion. Opportunities for new product development, focusing on personalization and improved user experience, will play a crucial role in future growth. The integration of AI and data analytics will further enhance the capabilities of existing devices. Strategic partnerships and collaborations among players will help in driving innovation.
Europe Diabetic Care Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring Devices
- 1.2.1. Sensors
- 1.2.2. Durables (Receivers and Transmitters)
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable Pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
Europe Diabetic Care Devices Market Segmentation By Geography
- 1. France
- 2. Germany
- 3. Italy
- 4. Spain
- 5. United Kingdom
- 6. Russia
- 7. Rest of Europe
Europe Diabetic Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.18% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income
- 3.3. Market Restrains
- 3.3.1. High Cost Associated with the Digital Dentistry
- 3.4. Market Trends
- 3.4.1. The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring Devices
- 5.1.2.1. Sensors
- 5.1.2.2. Durables (Receivers and Transmitters)
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable Pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. France
- 5.3.2. Germany
- 5.3.3. Italy
- 5.3.4. Spain
- 5.3.5. United Kingdom
- 5.3.6. Russia
- 5.3.7. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. France Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring Devices
- 6.1.2.1. Sensors
- 6.1.2.2. Durables (Receivers and Transmitters)
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Cartridges in Reusable Pens
- 6.2.4. Insulin Disposable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. Germany Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring Devices
- 7.1.2.1. Sensors
- 7.1.2.2. Durables (Receivers and Transmitters)
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Cartridges in Reusable Pens
- 7.2.4. Insulin Disposable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Italy Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring Devices
- 8.1.2.1. Sensors
- 8.1.2.2. Durables (Receivers and Transmitters)
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Cartridges in Reusable Pens
- 8.2.4. Insulin Disposable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Spain Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring Devices
- 9.1.2.1. Sensors
- 9.1.2.2. Durables (Receivers and Transmitters)
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Cartridges in Reusable Pens
- 9.2.4. Insulin Disposable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. United Kingdom Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring Devices
- 10.1.2.1. Sensors
- 10.1.2.2. Durables (Receivers and Transmitters)
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Cartridges in Reusable Pens
- 10.2.4. Insulin Disposable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Russia Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.1.1.1. Glucometer Devices
- 11.1.1.2. Blood Glucose Test Strips
- 11.1.1.3. Lancets
- 11.1.2. Continuous Glucose Monitoring Devices
- 11.1.2.1. Sensors
- 11.1.2.2. Durables (Receivers and Transmitters)
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.2. Market Analysis, Insights and Forecast - by Management Devices
- 11.2.1. Insulin Pump
- 11.2.1.1. Insulin Pump Device
- 11.2.1.2. Insulin Pump Reservoir
- 11.2.1.3. Infusion Set
- 11.2.2. Insulin Syringes
- 11.2.3. Cartridges in Reusable Pens
- 11.2.4. Insulin Disposable Pens
- 11.2.5. Jet Injectors
- 11.2.1. Insulin Pump
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12. Rest of Europe Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12.1.1. Self-monitoring Blood Glucose Devices
- 12.1.1.1. Glucometer Devices
- 12.1.1.2. Blood Glucose Test Strips
- 12.1.1.3. Lancets
- 12.1.2. Continuous Glucose Monitoring Devices
- 12.1.2.1. Sensors
- 12.1.2.2. Durables (Receivers and Transmitters)
- 12.1.1. Self-monitoring Blood Glucose Devices
- 12.2. Market Analysis, Insights and Forecast - by Management Devices
- 12.2.1. Insulin Pump
- 12.2.1.1. Insulin Pump Device
- 12.2.1.2. Insulin Pump Reservoir
- 12.2.1.3. Infusion Set
- 12.2.2. Insulin Syringes
- 12.2.3. Cartridges in Reusable Pens
- 12.2.4. Insulin Disposable Pens
- 12.2.5. Jet Injectors
- 12.2.1. Insulin Pump
- 12.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 13. Germany Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 14. France Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 15. Italy Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 16. United Kingdom Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 17. Netherlands Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 18. Sweden Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 19. Rest of Europe Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 20. Competitive Analysis
- 20.1. Market Share Analysis 2024
- 20.2. Company Profiles
- 20.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 20.2.1.1. Overview
- 20.2.1.2. Products
- 20.2.1.3. SWOT Analysis
- 20.2.1.4. Recent Developments
- 20.2.1.5. Financials (Based on Availability)
- 20.2.2 Agamatrix Inc
- 20.2.2.1. Overview
- 20.2.2.2. Products
- 20.2.2.3. SWOT Analysis
- 20.2.2.4. Recent Developments
- 20.2.2.5. Financials (Based on Availability)
- 20.2.3 Self-monitoring Blood Glucose Devices
- 20.2.3.1. Overview
- 20.2.3.2. Products
- 20.2.3.3. SWOT Analysis
- 20.2.3.4. Recent Developments
- 20.2.3.5. Financials (Based on Availability)
- 20.2.4 Roche Diabetes Care
- 20.2.4.1. Overview
- 20.2.4.2. Products
- 20.2.4.3. SWOT Analysis
- 20.2.4.4. Recent Developments
- 20.2.4.5. Financials (Based on Availability)
- 20.2.5 Bionime Corporation
- 20.2.5.1. Overview
- 20.2.5.2. Products
- 20.2.5.3. SWOT Analysis
- 20.2.5.4. Recent Developments
- 20.2.5.5. Financials (Based on Availability)
- 20.2.6 Sanofi
- 20.2.6.1. Overview
- 20.2.6.2. Products
- 20.2.6.3. SWOT Analysis
- 20.2.6.4. Recent Developments
- 20.2.6.5. Financials (Based on Availability)
- 20.2.7 Eli Lilly
- 20.2.7.1. Overview
- 20.2.7.2. Products
- 20.2.7.3. SWOT Analysis
- 20.2.7.4. Recent Developments
- 20.2.7.5. Financials (Based on Availability)
- 20.2.8 Novo Nordisk A/S
- 20.2.8.1. Overview
- 20.2.8.2. Products
- 20.2.8.3. SWOT Analysis
- 20.2.8.4. Recent Developments
- 20.2.8.5. Financials (Based on Availability)
- 20.2.9 Abbott Diabetes Care
- 20.2.9.1. Overview
- 20.2.9.2. Products
- 20.2.9.3. SWOT Analysis
- 20.2.9.4. Recent Developments
- 20.2.9.5. Financials (Based on Availability)
- 20.2.10 LifeScan
- 20.2.10.1. Overview
- 20.2.10.2. Products
- 20.2.10.3. SWOT Analysis
- 20.2.10.4. Recent Developments
- 20.2.10.5. Financials (Based on Availability)
- 20.2.11 Medtronic
- 20.2.11.1. Overview
- 20.2.11.2. Products
- 20.2.11.3. SWOT Analysis
- 20.2.11.4. Recent Developments
- 20.2.11.5. Financials (Based on Availability)
- 20.2.12 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 20.2.12.1. Overview
- 20.2.12.2. Products
- 20.2.12.3. SWOT Analysis
- 20.2.12.4. Recent Developments
- 20.2.12.5. Financials (Based on Availability)
- 20.2.13 Insulin Device
- 20.2.13.1. Overview
- 20.2.13.2. Products
- 20.2.13.3. SWOT Analysis
- 20.2.13.4. Recent Developments
- 20.2.13.5. Financials (Based on Availability)
- 20.2.14 Dexcom Inc
- 20.2.14.1. Overview
- 20.2.14.2. Products
- 20.2.14.3. SWOT Analysis
- 20.2.14.4. Recent Developments
- 20.2.14.5. Financials (Based on Availability)
- 20.2.15 Continuous Glucose Monitoring Devices
- 20.2.15.1. Overview
- 20.2.15.2. Products
- 20.2.15.3. SWOT Analysis
- 20.2.15.4. Recent Developments
- 20.2.15.5. Financials (Based on Availability)
- 20.2.16 Ascensia Diabetes Care
- 20.2.16.1. Overview
- 20.2.16.2. Products
- 20.2.16.3. SWOT Analysis
- 20.2.16.4. Recent Developments
- 20.2.16.5. Financials (Based on Availability)
- 20.2.17 Insulet Corporation
- 20.2.17.1. Overview
- 20.2.17.2. Products
- 20.2.17.3. SWOT Analysis
- 20.2.17.4. Recent Developments
- 20.2.17.5. Financials (Based on Availability)
- 20.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
List of Figures
- Figure 1: Europe Diabetic Care Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Europe Diabetic Care Devices Market Share (%) by Company 2024
List of Tables
- Table 1: Europe Diabetic Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Europe Diabetic Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Germany Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: France Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Italy Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: United Kingdom Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Netherlands Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Sweden Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Rest of Europe Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 14: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 15: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 16: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 17: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 18: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 19: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 20: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 21: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 22: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 23: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 24: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 25: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 26: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 27: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 28: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 29: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 30: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 31: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 32: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 33: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Diabetic Care Devices Market?
The projected CAGR is approximately 6.18%.
2. Which companies are prominent players in the Europe Diabetic Care Devices Market?
Key companies in the market include Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Agamatrix Inc, Self-monitoring Blood Glucose Devices, Roche Diabetes Care, Bionime Corporation, Sanofi, Eli Lilly, Novo Nordisk A/S, Abbott Diabetes Care, LifeScan, Medtronic, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, Insulin Device, Dexcom Inc, Continuous Glucose Monitoring Devices, Ascensia Diabetes Care, Insulet Corporation.
3. What are the main segments of the Europe Diabetic Care Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 8.03 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income.
6. What are the notable trends driving market growth?
The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost Associated with the Digital Dentistry.
8. Can you provide examples of recent developments in the market?
Feburary 2024: Dexcom launched real-time CGM solution Dexcom ONE+ in Europe. Dexcom ONE+ is a customisable continuous glucose monitoring solution that can be worn at three different location on the body.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Diabetic Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Diabetic Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Diabetic Care Devices Market?
To stay informed about further developments, trends, and reports in the Europe Diabetic Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
